Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)

NCT05045508 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: OC-01 (varenicline 0.6mg/ml) nasal spray
DRUG: Placebo (vehicle) Nasal Spray

Sponsor

Brandon Baartman